nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CES2—Irinotecan—pancreatic cancer	0.489	0.611	CbGbCtD
Prasugrel—CYP2B6—Tamoxifen—pancreatic cancer	0.0425	0.0531	CbGbCtD
Prasugrel—ALB—Erlotinib—pancreatic cancer	0.0354	0.0442	CbGbCtD
Prasugrel—CYP2B6—Irinotecan—pancreatic cancer	0.0326	0.0408	CbGbCtD
Prasugrel—ALB—Irinotecan—pancreatic cancer	0.032	0.0399	CbGbCtD
Prasugrel—ALB—Fluorouracil—pancreatic cancer	0.0307	0.0383	CbGbCtD
Prasugrel—CYP2C19—Tamoxifen—pancreatic cancer	0.027	0.0337	CbGbCtD
Prasugrel—CYP2C9—Tamoxifen—pancreatic cancer	0.0224	0.028	CbGbCtD
Prasugrel—CYP2B6—Doxorubicin—pancreatic cancer	0.0178	0.0223	CbGbCtD
Prasugrel—CYP2C9—Fluorouracil—pancreatic cancer	0.0165	0.0207	CbGbCtD
Prasugrel—CYP3A4—Tamoxifen—pancreatic cancer	0.013	0.0163	CbGbCtD
Prasugrel—CYP3A4—Erlotinib—pancreatic cancer	0.0111	0.0139	CbGbCtD
Prasugrel—CYP3A4—Irinotecan—pancreatic cancer	0.01	0.0125	CbGbCtD
Prasugrel—CYP3A4—Docetaxel—pancreatic cancer	0.00734	0.00918	CbGbCtD
Prasugrel—CYP3A4—Sunitinib—pancreatic cancer	0.00731	0.00913	CbGbCtD
Prasugrel—CYP3A4—Doxorubicin—pancreatic cancer	0.00547	0.00684	CbGbCtD
Prasugrel—Urethral disorder—Sunitinib—pancreatic cancer	0.000589	0.00434	CcSEcCtD
Prasugrel—Back pain—Erlotinib—pancreatic cancer	0.000584	0.00431	CcSEcCtD
Prasugrel—Haemoptysis—Doxorubicin—pancreatic cancer	0.000574	0.00423	CcSEcCtD
Prasugrel—Anaemia—Tamoxifen—pancreatic cancer	0.000564	0.00416	CcSEcCtD
Prasugrel—Eye disorder—Sunitinib—pancreatic cancer	0.000561	0.00414	CcSEcCtD
Prasugrel—Angioedema—Tamoxifen—pancreatic cancer	0.000558	0.00411	CcSEcCtD
Prasugrel—Leukopenia—Tamoxifen—pancreatic cancer	0.000546	0.00403	CcSEcCtD
Prasugrel—Angiopathy—Sunitinib—pancreatic cancer	0.000545	0.00402	CcSEcCtD
Prasugrel—Immune system disorder—Sunitinib—pancreatic cancer	0.000542	0.004	CcSEcCtD
Prasugrel—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000541	0.00399	CcSEcCtD
Prasugrel—Neoplasm malignant—Epirubicin—pancreatic cancer	0.000538	0.00396	CcSEcCtD
Prasugrel—Cough—Tamoxifen—pancreatic cancer	0.000532	0.00393	CcSEcCtD
Prasugrel—Hypertension—Tamoxifen—pancreatic cancer	0.000527	0.00388	CcSEcCtD
Prasugrel—Cough—Erlotinib—pancreatic cancer	0.000527	0.00388	CcSEcCtD
Prasugrel—Atrial fibrillation—Docetaxel—pancreatic cancer	0.000521	0.00384	CcSEcCtD
Prasugrel—Haematuria—Gemcitabine—pancreatic cancer	0.000512	0.00377	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00051	0.00376	CcSEcCtD
Prasugrel—Rectal haemorrhage—Epirubicin—pancreatic cancer	0.000508	0.00375	CcSEcCtD
Prasugrel—Back pain—Sunitinib—pancreatic cancer	0.000506	0.00373	CcSEcCtD
Prasugrel—Bradycardia—Irinotecan—pancreatic cancer	0.000503	0.00371	CcSEcCtD
Prasugrel—Epistaxis—Fluorouracil—pancreatic cancer	0.000498	0.00367	CcSEcCtD
Prasugrel—Neoplasm malignant—Doxorubicin—pancreatic cancer	0.000498	0.00367	CcSEcCtD
Prasugrel—Haemoglobin—Irinotecan—pancreatic cancer	0.000497	0.00366	CcSEcCtD
Prasugrel—Haemorrhage—Irinotecan—pancreatic cancer	0.000495	0.00365	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000494	0.00364	CcSEcCtD
Prasugrel—Pain in extremity—Docetaxel—pancreatic cancer	0.000494	0.00364	CcSEcCtD
Prasugrel—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000488	0.00359	CcSEcCtD
Prasugrel—Haemoglobin—Gemcitabine—pancreatic cancer	0.000484	0.00357	CcSEcCtD
Prasugrel—Anaemia—Sunitinib—pancreatic cancer	0.000483	0.00356	CcSEcCtD
Prasugrel—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000482	0.00356	CcSEcCtD
Prasugrel—Haemorrhage—Gemcitabine—pancreatic cancer	0.000482	0.00355	CcSEcCtD
Prasugrel—Skin disorder—Erlotinib—pancreatic cancer	0.000479	0.00353	CcSEcCtD
Prasugrel—Angioedema—Sunitinib—pancreatic cancer	0.000478	0.00352	CcSEcCtD
Prasugrel—Haemoglobin—Fluorouracil—pancreatic cancer	0.000476	0.00351	CcSEcCtD
Prasugrel—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000476	0.00351	CcSEcCtD
Prasugrel—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000475	0.0035	CcSEcCtD
Prasugrel—Haemorrhage—Fluorouracil—pancreatic cancer	0.000474	0.00349	CcSEcCtD
Prasugrel—Urethral disorder—Gemcitabine—pancreatic cancer	0.000472	0.00348	CcSEcCtD
Prasugrel—Rectal haemorrhage—Doxorubicin—pancreatic cancer	0.00047	0.00347	CcSEcCtD
Prasugrel—Leukopenia—Sunitinib—pancreatic cancer	0.000468	0.00345	CcSEcCtD
Prasugrel—Cough—Sunitinib—pancreatic cancer	0.000456	0.00336	CcSEcCtD
Prasugrel—Hypertension—Sunitinib—pancreatic cancer	0.000451	0.00333	CcSEcCtD
Prasugrel—Angiopathy—Irinotecan—pancreatic cancer	0.000449	0.00331	CcSEcCtD
Prasugrel—Immune system disorder—Irinotecan—pancreatic cancer	0.000447	0.00329	CcSEcCtD
Prasugrel—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000446	0.00329	CcSEcCtD
Prasugrel—Dyspnoea—Tamoxifen—pancreatic cancer	0.000444	0.00327	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000442	0.00326	CcSEcCtD
Prasugrel—Dyspnoea—Erlotinib—pancreatic cancer	0.000439	0.00324	CcSEcCtD
Prasugrel—Angiopathy—Gemcitabine—pancreatic cancer	0.000437	0.00322	CcSEcCtD
Prasugrel—Immune system disorder—Gemcitabine—pancreatic cancer	0.000435	0.00321	CcSEcCtD
Prasugrel—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000434	0.0032	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00043	0.00317	CcSEcCtD
Prasugrel—Fatigue—Tamoxifen—pancreatic cancer	0.000429	0.00317	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000425	0.00314	CcSEcCtD
Prasugrel—Fatigue—Erlotinib—pancreatic cancer	0.000425	0.00313	CcSEcCtD
Prasugrel—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000418	0.00308	CcSEcCtD
Prasugrel—Back pain—Irinotecan—pancreatic cancer	0.000416	0.00307	CcSEcCtD
Prasugrel—Ecchymosis—Epirubicin—pancreatic cancer	0.000415	0.00306	CcSEcCtD
Prasugrel—Neoplasm—Epirubicin—pancreatic cancer	0.000415	0.00306	CcSEcCtD
Prasugrel—Skin disorder—Sunitinib—pancreatic cancer	0.000414	0.00305	CcSEcCtD
Prasugrel—Back pain—Gemcitabine—pancreatic cancer	0.000406	0.00299	CcSEcCtD
Prasugrel—Anaemia—Irinotecan—pancreatic cancer	0.000398	0.00293	CcSEcCtD
Prasugrel—Body temperature increased—Erlotinib—pancreatic cancer	0.00039	0.00287	CcSEcCtD
Prasugrel—Anaemia—Gemcitabine—pancreatic cancer	0.000388	0.00286	CcSEcCtD
Prasugrel—Leukopenia—Irinotecan—pancreatic cancer	0.000385	0.00284	CcSEcCtD
Prasugrel—Ecchymosis—Doxorubicin—pancreatic cancer	0.000384	0.00283	CcSEcCtD
Prasugrel—Neoplasm—Doxorubicin—pancreatic cancer	0.000384	0.00283	CcSEcCtD
Prasugrel—Anaemia—Fluorouracil—pancreatic cancer	0.000381	0.00281	CcSEcCtD
Prasugrel—Dyspnoea—Sunitinib—pancreatic cancer	0.00038	0.0028	CcSEcCtD
Prasugrel—Cough—Irinotecan—pancreatic cancer	0.000376	0.00277	CcSEcCtD
Prasugrel—Leukopenia—Gemcitabine—pancreatic cancer	0.000375	0.00277	CcSEcCtD
Prasugrel—Hypertension—Irinotecan—pancreatic cancer	0.000372	0.00274	CcSEcCtD
Prasugrel—Leukopenia—Fluorouracil—pancreatic cancer	0.000369	0.00272	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000368	0.00271	CcSEcCtD
Prasugrel—Fatigue—Sunitinib—pancreatic cancer	0.000368	0.00271	CcSEcCtD
Prasugrel—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000367	0.0027	CcSEcCtD
Prasugrel—Cough—Gemcitabine—pancreatic cancer	0.000366	0.0027	CcSEcCtD
Prasugrel—Hypertension—Gemcitabine—pancreatic cancer	0.000362	0.00267	CcSEcCtD
Prasugrel—Epistaxis—Docetaxel—pancreatic cancer	0.000359	0.00265	CcSEcCtD
Prasugrel—Asthenia—Tamoxifen—pancreatic cancer	0.000357	0.00263	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000355	0.00261	CcSEcCtD
Prasugrel—Asthenia—Erlotinib—pancreatic cancer	0.000354	0.00261	CcSEcCtD
Prasugrel—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000351	0.00259	CcSEcCtD
Prasugrel—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000344	0.00254	CcSEcCtD
Prasugrel—Haemoglobin—Docetaxel—pancreatic cancer	0.000344	0.00253	CcSEcCtD
Prasugrel—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000342	0.00252	CcSEcCtD
Prasugrel—Haemorrhage—Docetaxel—pancreatic cancer	0.000342	0.00252	CcSEcCtD
Prasugrel—Diarrhoea—Tamoxifen—pancreatic cancer	0.000341	0.00251	CcSEcCtD
Prasugrel—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.00034	0.00251	CcSEcCtD
Prasugrel—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000338	0.00249	CcSEcCtD
Prasugrel—Body temperature increased—Sunitinib—pancreatic cancer	0.000337	0.00249	CcSEcCtD
Prasugrel—Diarrhoea—Erlotinib—pancreatic cancer	0.000337	0.00249	CcSEcCtD
Prasugrel—Oedema peripheral—Docetaxel—pancreatic cancer	0.000337	0.00248	CcSEcCtD
Prasugrel—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000337	0.00248	CcSEcCtD
Prasugrel—Urethral disorder—Docetaxel—pancreatic cancer	0.000335	0.00247	CcSEcCtD
Prasugrel—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000335	0.00247	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000333	0.00246	CcSEcCtD
Prasugrel—Pain in extremity—Epirubicin—pancreatic cancer	0.000333	0.00246	CcSEcCtD
Prasugrel—Skin disorder—Gemcitabine—pancreatic cancer	0.000332	0.00245	CcSEcCtD
Prasugrel—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000329	0.00243	CcSEcCtD
Prasugrel—Dizziness—Tamoxifen—pancreatic cancer	0.000329	0.00243	CcSEcCtD
Prasugrel—Hypotension—Irinotecan—pancreatic cancer	0.000328	0.00242	CcSEcCtD
Prasugrel—Dizziness—Erlotinib—pancreatic cancer	0.000326	0.0024	CcSEcCtD
Prasugrel—Hypotension—Gemcitabine—pancreatic cancer	0.00032	0.00236	CcSEcCtD
Prasugrel—Eye disorder—Docetaxel—pancreatic cancer	0.000319	0.00236	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000315	0.00232	CcSEcCtD
Prasugrel—Hypotension—Fluorouracil—pancreatic cancer	0.000314	0.00232	CcSEcCtD
Prasugrel—Hypersensitivity—Sunitinib—pancreatic cancer	0.000314	0.00232	CcSEcCtD
Prasugrel—Rash—Tamoxifen—pancreatic cancer	0.000314	0.00231	CcSEcCtD
Prasugrel—Dermatitis—Tamoxifen—pancreatic cancer	0.000314	0.00231	CcSEcCtD
Prasugrel—Dyspnoea—Irinotecan—pancreatic cancer	0.000313	0.00231	CcSEcCtD
Prasugrel—Headache—Tamoxifen—pancreatic cancer	0.000312	0.0023	CcSEcCtD
Prasugrel—Rash—Erlotinib—pancreatic cancer	0.000311	0.00229	CcSEcCtD
Prasugrel—Dermatitis—Erlotinib—pancreatic cancer	0.00031	0.00229	CcSEcCtD
Prasugrel—Angiopathy—Docetaxel—pancreatic cancer	0.00031	0.00229	CcSEcCtD
Prasugrel—Immune system disorder—Docetaxel—pancreatic cancer	0.000309	0.00228	CcSEcCtD
Prasugrel—Headache—Erlotinib—pancreatic cancer	0.000309	0.00228	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—pancreatic cancer	0.000308	0.00227	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000308	0.00227	CcSEcCtD
Prasugrel—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000308	0.00227	CcSEcCtD
Prasugrel—Asthenia—Sunitinib—pancreatic cancer	0.000306	0.00226	CcSEcCtD
Prasugrel—Dyspnoea—Gemcitabine—pancreatic cancer	0.000305	0.00225	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000303	0.00224	CcSEcCtD
Prasugrel—Fatigue—Irinotecan—pancreatic cancer	0.000303	0.00223	CcSEcCtD
Prasugrel—Dyspnoea—Fluorouracil—pancreatic cancer	0.0003	0.00221	CcSEcCtD
Prasugrel—Nausea—Tamoxifen—pancreatic cancer	0.000296	0.00218	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000295	0.00218	CcSEcCtD
Prasugrel—Fatigue—Gemcitabine—pancreatic cancer	0.000295	0.00218	CcSEcCtD
Prasugrel—Nausea—Erlotinib—pancreatic cancer	0.000293	0.00216	CcSEcCtD
Prasugrel—Diarrhoea—Sunitinib—pancreatic cancer	0.000292	0.00215	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000291	0.00214	CcSEcCtD
Prasugrel—Back pain—Docetaxel—pancreatic cancer	0.000288	0.00212	CcSEcCtD
Prasugrel—Dizziness—Sunitinib—pancreatic cancer	0.000282	0.00208	CcSEcCtD
Prasugrel—Body temperature increased—Irinotecan—pancreatic cancer	0.000278	0.00205	CcSEcCtD
Prasugrel—Anaemia—Docetaxel—pancreatic cancer	0.000275	0.00203	CcSEcCtD
Prasugrel—Body temperature increased—Gemcitabine—pancreatic cancer	0.000271	0.00199	CcSEcCtD
Prasugrel—Rash—Sunitinib—pancreatic cancer	0.000269	0.00198	CcSEcCtD
Prasugrel—Dermatitis—Sunitinib—pancreatic cancer	0.000269	0.00198	CcSEcCtD
Prasugrel—Headache—Sunitinib—pancreatic cancer	0.000267	0.00197	CcSEcCtD
Prasugrel—Leukopenia—Docetaxel—pancreatic cancer	0.000266	0.00196	CcSEcCtD
Prasugrel—Body temperature increased—Fluorouracil—pancreatic cancer	0.000266	0.00196	CcSEcCtD
Prasugrel—Cough—Docetaxel—pancreatic cancer	0.00026	0.00191	CcSEcCtD
Prasugrel—Hypersensitivity—Irinotecan—pancreatic cancer	0.000259	0.00191	CcSEcCtD
Prasugrel—Hypertension—Docetaxel—pancreatic cancer	0.000257	0.00189	CcSEcCtD
Prasugrel—Nausea—Sunitinib—pancreatic cancer	0.000253	0.00187	CcSEcCtD
Prasugrel—Asthenia—Irinotecan—pancreatic cancer	0.000252	0.00186	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000252	0.00185	CcSEcCtD
Prasugrel—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000248	0.00183	CcSEcCtD
Prasugrel—Asthenia—Gemcitabine—pancreatic cancer	0.000246	0.00181	CcSEcCtD
Prasugrel—Haematuria—Epirubicin—pancreatic cancer	0.000245	0.00181	CcSEcCtD
Prasugrel—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000243	0.00179	CcSEcCtD
Prasugrel—Epistaxis—Epirubicin—pancreatic cancer	0.000242	0.00179	CcSEcCtD
Prasugrel—Diarrhoea—Irinotecan—pancreatic cancer	0.00024	0.00177	CcSEcCtD
Prasugrel—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000238	0.00175	CcSEcCtD
Prasugrel—Skin disorder—Docetaxel—pancreatic cancer	0.000236	0.00174	CcSEcCtD
Prasugrel—Bradycardia—Epirubicin—pancreatic cancer	0.000235	0.00173	CcSEcCtD
Prasugrel—Diarrhoea—Gemcitabine—pancreatic cancer	0.000234	0.00173	CcSEcCtD
Prasugrel—Dizziness—Irinotecan—pancreatic cancer	0.000232	0.00171	CcSEcCtD
Prasugrel—Haemoglobin—Epirubicin—pancreatic cancer	0.000232	0.00171	CcSEcCtD
Prasugrel—Haemorrhage—Epirubicin—pancreatic cancer	0.000231	0.0017	CcSEcCtD
Prasugrel—Diarrhoea—Fluorouracil—pancreatic cancer	0.00023	0.0017	CcSEcCtD
Prasugrel—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000228	0.00168	CcSEcCtD
Prasugrel—Oedema peripheral—Epirubicin—pancreatic cancer	0.000227	0.00167	CcSEcCtD
Prasugrel—Hypotension—Docetaxel—pancreatic cancer	0.000227	0.00167	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—pancreatic cancer	0.000227	0.00167	CcSEcCtD
Prasugrel—Urethral disorder—Epirubicin—pancreatic cancer	0.000226	0.00167	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—pancreatic cancer	0.000224	0.00165	CcSEcCtD
Prasugrel—Dizziness—Fluorouracil—pancreatic cancer	0.000223	0.00164	CcSEcCtD
Prasugrel—Rash—Irinotecan—pancreatic cancer	0.000222	0.00163	CcSEcCtD
Prasugrel—Dermatitis—Irinotecan—pancreatic cancer	0.000221	0.00163	CcSEcCtD
Prasugrel—Headache—Irinotecan—pancreatic cancer	0.00022	0.00162	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—pancreatic cancer	0.000217	0.0016	CcSEcCtD
Prasugrel—Dyspnoea—Docetaxel—pancreatic cancer	0.000217	0.0016	CcSEcCtD
Prasugrel—Rash—Gemcitabine—pancreatic cancer	0.000216	0.00159	CcSEcCtD
Prasugrel—Dermatitis—Gemcitabine—pancreatic cancer	0.000216	0.00159	CcSEcCtD
Prasugrel—Eye disorder—Epirubicin—pancreatic cancer	0.000215	0.00159	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—pancreatic cancer	0.000214	0.00158	CcSEcCtD
Prasugrel—Headache—Gemcitabine—pancreatic cancer	0.000214	0.00158	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—pancreatic cancer	0.000213	0.00157	CcSEcCtD
Prasugrel—Rash—Fluorouracil—pancreatic cancer	0.000212	0.00156	CcSEcCtD
Prasugrel—Dermatitis—Fluorouracil—pancreatic cancer	0.000212	0.00156	CcSEcCtD
Prasugrel—Headache—Fluorouracil—pancreatic cancer	0.000211	0.00155	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000211	0.00155	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00021	0.00155	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00021	0.00155	CcSEcCtD
Prasugrel—Fatigue—Docetaxel—pancreatic cancer	0.000209	0.00154	CcSEcCtD
Prasugrel—Angiopathy—Epirubicin—pancreatic cancer	0.000209	0.00154	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—pancreatic cancer	0.000209	0.00154	CcSEcCtD
Prasugrel—Nausea—Irinotecan—pancreatic cancer	0.000209	0.00154	CcSEcCtD
Prasugrel—Immune system disorder—Epirubicin—pancreatic cancer	0.000208	0.00154	CcSEcCtD
Prasugrel—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000208	0.00153	CcSEcCtD
Prasugrel—Nausea—Gemcitabine—pancreatic cancer	0.000203	0.0015	CcSEcCtD
Prasugrel—Nausea—Fluorouracil—pancreatic cancer	0.0002	0.00147	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—pancreatic cancer	0.000199	0.00147	CcSEcCtD
Prasugrel—Back pain—Epirubicin—pancreatic cancer	0.000194	0.00143	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—pancreatic cancer	0.000194	0.00143	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—pancreatic cancer	0.000193	0.00142	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000192	0.00142	CcSEcCtD
Prasugrel—Body temperature increased—Docetaxel—pancreatic cancer	0.000192	0.00142	CcSEcCtD
Prasugrel—Anaemia—Epirubicin—pancreatic cancer	0.000186	0.00137	CcSEcCtD
Prasugrel—Leukopenia—Epirubicin—pancreatic cancer	0.00018	0.00132	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—pancreatic cancer	0.00018	0.00132	CcSEcCtD
Prasugrel—Hypersensitivity—Docetaxel—pancreatic cancer	0.000179	0.00132	CcSEcCtD
Prasugrel—Cough—Epirubicin—pancreatic cancer	0.000175	0.00129	CcSEcCtD
Prasugrel—Asthenia—Docetaxel—pancreatic cancer	0.000174	0.00128	CcSEcCtD
Prasugrel—Hypertension—Epirubicin—pancreatic cancer	0.000173	0.00128	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—pancreatic cancer	0.000172	0.00127	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00017	0.00125	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—pancreatic cancer	0.000166	0.00123	CcSEcCtD
Prasugrel—Diarrhoea—Docetaxel—pancreatic cancer	0.000166	0.00123	CcSEcCtD
Prasugrel—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000164	0.00121	CcSEcCtD
Prasugrel—Cough—Doxorubicin—pancreatic cancer	0.000162	0.00119	CcSEcCtD
Prasugrel—Dizziness—Docetaxel—pancreatic cancer	0.000161	0.00118	CcSEcCtD
Prasugrel—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00016	0.00118	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—pancreatic cancer	0.00016	0.00118	CcSEcCtD
Prasugrel—Skin disorder—Epirubicin—pancreatic cancer	0.000159	0.00117	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000157	0.00116	CcSEcCtD
Prasugrel—Rash—Docetaxel—pancreatic cancer	0.000153	0.00113	CcSEcCtD
Prasugrel—Hypotension—Epirubicin—pancreatic cancer	0.000153	0.00113	CcSEcCtD
Prasugrel—Dermatitis—Docetaxel—pancreatic cancer	0.000153	0.00113	CcSEcCtD
Prasugrel—Headache—Docetaxel—pancreatic cancer	0.000152	0.00112	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000152	0.00112	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000148	0.00109	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—pancreatic cancer	0.000147	0.00109	CcSEcCtD
Prasugrel—Dyspnoea—Epirubicin—pancreatic cancer	0.000146	0.00108	CcSEcCtD
Prasugrel—Nausea—Docetaxel—pancreatic cancer	0.000144	0.00106	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—pancreatic cancer	0.000142	0.00104	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000141	0.00104	CcSEcCtD
Prasugrel—Fatigue—Epirubicin—pancreatic cancer	0.000141	0.00104	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—pancreatic cancer	0.000135	0.000996	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000131	0.000965	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—pancreatic cancer	0.000131	0.000963	CcSEcCtD
Prasugrel—Body temperature increased—Epirubicin—pancreatic cancer	0.00013	0.000955	CcSEcCtD
Prasugrel—Hypersensitivity—Epirubicin—pancreatic cancer	0.000121	0.00089	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—pancreatic cancer	0.00012	0.000883	CcSEcCtD
Prasugrel—Asthenia—Epirubicin—pancreatic cancer	0.000118	0.000866	CcSEcCtD
Prasugrel—Diarrhoea—Epirubicin—pancreatic cancer	0.000112	0.000826	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000112	0.000823	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—pancreatic cancer	0.000109	0.000802	CcSEcCtD
Prasugrel—Dizziness—Epirubicin—pancreatic cancer	0.000108	0.000799	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—pancreatic cancer	0.000104	0.000765	CcSEcCtD
Prasugrel—Rash—Epirubicin—pancreatic cancer	0.000103	0.000761	CcSEcCtD
Prasugrel—Dermatitis—Epirubicin—pancreatic cancer	0.000103	0.000761	CcSEcCtD
Prasugrel—Headache—Epirubicin—pancreatic cancer	0.000103	0.000757	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—pancreatic cancer	0.0001	0.000739	CcSEcCtD
Prasugrel—Nausea—Epirubicin—pancreatic cancer	9.73e-05	0.000717	CcSEcCtD
Prasugrel—Rash—Doxorubicin—pancreatic cancer	9.56e-05	0.000705	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—pancreatic cancer	9.55e-05	0.000704	CcSEcCtD
Prasugrel—Headache—Doxorubicin—pancreatic cancer	9.5e-05	0.0007	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—pancreatic cancer	9e-05	0.000664	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—CNR1—pancreatic cancer	8.25e-05	0.00128	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CG—pancreatic cancer	8.24e-05	0.00128	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NRP1—pancreatic cancer	8.19e-05	0.00127	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PPP2R5B—pancreatic cancer	8.19e-05	0.00127	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—EGF—pancreatic cancer	8.14e-05	0.00127	CbGpPWpGaD
Prasugrel—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	8.1e-05	0.00126	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—GCG—pancreatic cancer	7.97e-05	0.00124	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	7.9e-05	0.00123	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HEY2—pancreatic cancer	7.89e-05	0.00123	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GAST—pancreatic cancer	7.7e-05	0.0012	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AGTR1—pancreatic cancer	7.6e-05	0.00118	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	7.47e-05	0.00116	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SCT—pancreatic cancer	7.3e-05	0.00113	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HEY1—pancreatic cancer	7.3e-05	0.00113	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CD—pancreatic cancer	7.24e-05	0.00113	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCK—pancreatic cancer	6.97e-05	0.00108	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CNR2—pancreatic cancer	6.79e-05	0.00105	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GLP1R—pancreatic cancer	6.79e-05	0.00105	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CXCL8—pancreatic cancer	6.78e-05	0.00105	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCKAR—pancreatic cancer	6.68e-05	0.00104	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	6.57e-05	0.00102	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—JAG2—pancreatic cancer	6.48e-05	0.00101	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MEN1—pancreatic cancer	6.38e-05	0.000992	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IFNA5—pancreatic cancer	6.35e-05	0.000987	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CB—pancreatic cancer	6.31e-05	0.000981	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	6.29e-05	0.000978	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	6.1e-05	0.000948	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SHH—pancreatic cancer	6.09e-05	0.000946	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH4—pancreatic cancer	6.05e-05	0.00094	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IAPP—pancreatic cancer	6.01e-05	0.000934	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PPP2R5B—pancreatic cancer	6e-05	0.000932	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTHLH—pancreatic cancer	5.77e-05	0.000897	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTCH1—pancreatic cancer	5.77e-05	0.000897	CbGpPWpGaD
Prasugrel—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	5.51e-05	0.000856	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—VEGFA—pancreatic cancer	5.35e-05	0.000831	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TNF—pancreatic cancer	5.35e-05	0.000831	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SST—pancreatic cancer	5.28e-05	0.00082	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.21e-05	0.000809	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—JAG1—pancreatic cancer	5.17e-05	0.000803	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH3—pancreatic cancer	5.14e-05	0.000799	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	5.1e-05	0.000792	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—SRC—pancreatic cancer	5.06e-05	0.000786	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—VEGFA—pancreatic cancer	4.93e-05	0.000766	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—TGFB1—pancreatic cancer	4.91e-05	0.000763	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CNR1—pancreatic cancer	4.87e-05	0.000757	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—NRAS—pancreatic cancer	4.87e-05	0.000756	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CG—pancreatic cancer	4.73e-05	0.000735	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TP53—pancreatic cancer	4.71e-05	0.000733	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GCG—pancreatic cancer	4.71e-05	0.000731	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	4.68e-05	0.000727	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.58e-05	0.000711	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TGFB1—pancreatic cancer	4.52e-05	0.000703	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AGTR1—pancreatic cancer	4.49e-05	0.000698	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STK11—pancreatic cancer	4.42e-05	0.000687	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	4.25e-05	0.00066	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—KRAS—pancreatic cancer	4.19e-05	0.000651	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CD—pancreatic cancer	4.16e-05	0.000646	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.02e-05	0.000624	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.99e-05	0.00062	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	3.97e-05	0.000617	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	3.92e-05	0.000609	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PRSS1—pancreatic cancer	3.92e-05	0.000609	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SMAD4—pancreatic cancer	3.87e-05	0.000602	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CA—pancreatic cancer	3.85e-05	0.000598	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCL8—pancreatic cancer	3.83e-05	0.000596	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HES1—pancreatic cancer	3.78e-05	0.000588	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—pancreatic cancer	3.72e-05	0.000579	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CB—pancreatic cancer	3.62e-05	0.000563	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CD44—pancreatic cancer	3.59e-05	0.000558	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—HRAS—pancreatic cancer	3.56e-05	0.000553	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	3.49e-05	0.000542	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CXCL8—pancreatic cancer	3.48e-05	0.000541	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IFNA1—pancreatic cancer	3.48e-05	0.000541	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ARG2—pancreatic cancer	3.4e-05	0.000528	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TERT—pancreatic cancer	3.32e-05	0.000515	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PRSS1—pancreatic cancer	3.3e-05	0.000513	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IFNA2—pancreatic cancer	3.24e-05	0.000503	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HIF1A—pancreatic cancer	3.17e-05	0.000493	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TSC2—pancreatic cancer	3.16e-05	0.000491	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—AKT1—pancreatic cancer	3.14e-05	0.000489	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APOE—pancreatic cancer	3.1e-05	0.000481	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	3.04e-05	0.000472	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KDR—pancreatic cancer	3.03e-05	0.000471	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—TYMP—pancreatic cancer	2.97e-05	0.000461	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.96e-05	0.00046	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NFKBIA—pancreatic cancer	2.88e-05	0.000448	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ARG2—pancreatic cancer	2.86e-05	0.000444	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH1—pancreatic cancer	2.86e-05	0.000444	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CG—pancreatic cancer	2.79e-05	0.000434	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—NRAS—pancreatic cancer	2.79e-05	0.000434	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGF—pancreatic cancer	2.76e-05	0.000429	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.7e-05	0.00042	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.57e-05	0.000399	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—EGFR—pancreatic cancer	2.54e-05	0.000395	CbGpPWpGaD
Prasugrel—ALB—Metabolism—TYMP—pancreatic cancer	2.5e-05	0.000388	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CD—pancreatic cancer	2.46e-05	0.000382	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	2.44e-05	0.000379	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.43e-05	0.000378	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—KRAS—pancreatic cancer	2.4e-05	0.000374	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GLP1R—pancreatic cancer	2.39e-05	0.000372	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.37e-05	0.000369	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—DPYD—pancreatic cancer	2.36e-05	0.000366	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ARG2—pancreatic cancer	2.34e-05	0.000364	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PLAU—pancreatic cancer	2.3e-05	0.000357	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.24e-05	0.000349	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	2.23e-05	0.000347	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CA—pancreatic cancer	2.21e-05	0.000343	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.18e-05	0.000338	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CB—pancreatic cancer	2.14e-05	0.000333	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.06e-05	0.000321	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL8—pancreatic cancer	2.06e-05	0.00032	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—TYMP—pancreatic cancer	2.05e-05	0.000318	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CG—pancreatic cancer	2.05e-05	0.000318	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—HRAS—pancreatic cancer	2.04e-05	0.000318	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—EGF—pancreatic cancer	2.02e-05	0.000314	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GLP1R—pancreatic cancer	2.02e-05	0.000313	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—AKT1—pancreatic cancer	1.99e-05	0.000309	CbGpPWpGaD
Prasugrel—ALB—Metabolism—DPYD—pancreatic cancer	1.98e-05	0.000308	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CASP3—pancreatic cancer	1.97e-05	0.000306	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—pancreatic cancer	1.92e-05	0.000298	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CTNNB1—pancreatic cancer	1.9e-05	0.000295	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC2A2—pancreatic cancer	1.88e-05	0.000292	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.86e-05	0.000289	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—pancreatic cancer	1.86e-05	0.000289	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.85e-05	0.000288	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.85e-05	0.000288	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTEN—pancreatic cancer	1.85e-05	0.000287	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.81e-05	0.000281	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AKT1—pancreatic cancer	1.8e-05	0.00028	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.8e-05	0.000279	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.8e-05	0.000279	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.78e-05	0.000277	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.78e-05	0.000277	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CD44—pancreatic cancer	1.73e-05	0.000269	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SRC—pancreatic cancer	1.72e-05	0.000267	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.69e-05	0.000262	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.69e-05	0.000262	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.67e-05	0.00026	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—pancreatic cancer	1.67e-05	0.00026	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GCG—pancreatic cancer	1.66e-05	0.000258	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—pancreatic cancer	1.65e-05	0.000257	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NRAS—pancreatic cancer	1.65e-05	0.000256	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.65e-05	0.000256	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.64e-05	0.000254	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.62e-05	0.000252	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.61e-05	0.000251	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.57e-05	0.000244	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—STK11—pancreatic cancer	1.56e-05	0.000242	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.54e-05	0.00024	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.54e-05	0.000239	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—pancreatic cancer	1.54e-05	0.000239	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—pancreatic cancer	1.53e-05	0.000238	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.52e-05	0.000237	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.51e-05	0.000235	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—pancreatic cancer	1.5e-05	0.000234	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.47e-05	0.000229	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.47e-05	0.000228	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CD44—pancreatic cancer	1.46e-05	0.000226	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.43e-05	0.000222	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KRAS—pancreatic cancer	1.42e-05	0.000221	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.41e-05	0.00022	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GCG—pancreatic cancer	1.4e-05	0.000217	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.35e-05	0.00021	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.34e-05	0.000209	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.34e-05	0.000208	CbGpPWpGaD
Prasugrel—ALB—Metabolism—STK11—pancreatic cancer	1.31e-05	0.000204	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CD44—pancreatic cancer	1.31e-05	0.000203	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—pancreatic cancer	1.3e-05	0.000203	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.28e-05	0.000199	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.27e-05	0.000197	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—pancreatic cancer	1.26e-05	0.000196	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SRC—pancreatic cancer	1.26e-05	0.000195	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GCG—pancreatic cancer	1.25e-05	0.000195	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.23e-05	0.000192	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—pancreatic cancer	1.22e-05	0.00019	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NRAS—pancreatic cancer	1.21e-05	0.000188	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HRAS—pancreatic cancer	1.21e-05	0.000188	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CD44—pancreatic cancer	1.19e-05	0.000185	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—STK11—pancreatic cancer	1.18e-05	0.000183	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.17e-05	0.000181	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.16e-05	0.00018	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GCG—pancreatic cancer	1.14e-05	0.000178	CbGpPWpGaD
Prasugrel—ALB—Metabolism—TYMS—pancreatic cancer	1.13e-05	0.000176	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—pancreatic cancer	1.12e-05	0.000174	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.11e-05	0.000172	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOE—pancreatic cancer	1.09e-05	0.00017	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.09e-05	0.000169	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—STK11—pancreatic cancer	1.07e-05	0.000167	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.07e-05	0.000166	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—pancreatic cancer	1.07e-05	0.000166	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KRAS—pancreatic cancer	1.04e-05	0.000162	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.02e-05	0.000158	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.01e-05	0.000158	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.01e-05	0.000157	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	9.85e-06	0.000153	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—pancreatic cancer	9.55e-06	0.000148	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARG—pancreatic cancer	9.51e-06	0.000148	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—TYMS—pancreatic cancer	9.25e-06	0.000144	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—pancreatic cancer	9.24e-06	0.000144	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOE—pancreatic cancer	9.19e-06	0.000143	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HRAS—pancreatic cancer	8.84e-06	0.000137	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.7e-06	0.000135	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	8.66e-06	0.000135	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—pancreatic cancer	8.29e-06	0.000129	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOE—pancreatic cancer	8.25e-06	0.000128	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARG—pancreatic cancer	8e-06	0.000124	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CD44—pancreatic cancer	7.87e-06	0.000122	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.81e-06	0.000121	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—pancreatic cancer	7.8e-06	0.000121	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	7.55e-06	0.000117	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GCG—pancreatic cancer	7.54e-06	0.000117	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOE—pancreatic cancer	7.52e-06	0.000117	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—pancreatic cancer	7.48e-06	0.000116	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	7.44e-06	0.000116	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CD—pancreatic cancer	7.29e-06	0.000113	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARG—pancreatic cancer	7.18e-06	0.000112	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.12e-06	0.000111	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—STK11—pancreatic cancer	7.09e-06	0.00011	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	6.79e-06	0.000105	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARG—pancreatic cancer	6.55e-06	0.000102	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	6.54e-06	0.000102	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTEN—pancreatic cancer	6.52e-06	0.000101	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CB—pancreatic cancer	6.35e-06	9.87e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—pancreatic cancer	6.3e-06	9.78e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.1e-06	9.48e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.97e-06	9.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	5.7e-06	8.86e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—pancreatic cancer	5.65e-06	8.78e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTEN—pancreatic cancer	5.49e-06	8.53e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	5.2e-06	8.08e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—pancreatic cancer	5.15e-06	8.01e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOE—pancreatic cancer	4.96e-06	7.71e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.93e-06	7.66e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	4.6e-06	7.15e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTEN—pancreatic cancer	4.49e-06	6.98e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.48e-06	6.96e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.32e-06	6.71e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.93e-06	6.11e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—pancreatic cancer	3.87e-06	6.02e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—pancreatic cancer	3.76e-06	5.84e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.48e-06	5.4e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.43e-06	5.33e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.4e-06	5.28e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	3.17e-06	4.93e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—pancreatic cancer	3.16e-06	4.92e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.96e-06	4.61e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.84e-06	4.41e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.59e-06	4.02e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.09e-06	3.25e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.71e-06	2.65e-05	CbGpPWpGaD
